This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Ali Ellebedy, Ph.D.
Leo Loeb Endowed Professor, Pathology & Immunology at Washington University School of Medicine
Speaker

Profile

Ali H. Ellebedy, Ph.D., Leo Loeb Endowed Professor in the Department of Pathology and Immunology, and the Co-Director of the Center for Vaccines and Immunity to Microbial Pathogens at Washington University School of Medicine in St. Louis. He is a viral immunologist with 16 years of experience studying murine and human B cell responses to viral infections and vaccination. Over the past ten years, he has been directly involved in the design and execution of over 20 vaccination studies in humans. He was the study PI of half of these studies. The focus of his research has been on viral pathogens, including seasonal and avian influenza, Ebola, Lassa, Chikungunya, and SARSCoV-2. He has unique expertise in the evaluation of B cell and antibody responses to vaccination that will guarantee the successful completion of the goals of this application.

Dr. Ellebedy earned a bachelor’s degree in Pharmaceutical Sciences from Cairo University School of Pharmacy, Cairo, Egypt in 2004 and his Ph.D. from the University of Tennessee Health Science Center, Memphis, Tennessee in 2011.

Throughout his career, Dr. Ellebedy has demonstrated his expertise through numerous publications and has received recognition with various prestigious awards.

Agenda Sessions

  • Germinal Center B Cell Response to mRNA Vaccination in Humans

    5:15pm